Value of post-operative reassessment of estrogen receptor alpha expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: L773:0167 6806 OR L773:1573 7217 > (2010-2014) > Value of post-opera...

Details
MARC

Bernsdorf, Mogens (author)

Value of post-operative reassessment of estrogen receptor alpha expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer

Article/chapterEnglish2011

Publisher, publication year, extent ...

2011-04-23
Springer Science and Business Media LLC,2011

Numbers

LIBRIS-ID:oai:lup.lub.lu.se:69645240-ddc5-474d-b765-757c3f28ada0
https://lup.lub.lu.se/record/2056779URI
https://doi.org/10.1007/s10549-011-1535-xDOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:art swepub-publicationtype
Subject category:ref swepub-contenttype

Notes

The NICE trial was designed to evaluate the possible benefits of adding epidermal growth factor receptor targeted therapy to neoadjuvant chemotherapy in patients with estrogen receptor alpha (ER) negative and operable breast cancer. Preclinical data have suggested that signalling through the ErbB receptors or downstream effectors may repress ER expression. Here the authors investigated whether gefitinib, given neoadjuvant in combination with epirubicin and cyclophosphamide (EC), could restore ER expression. Eligible patients in the NICE trial were women with unilateral, primary operable, ER negative invasive breast cancer a parts per thousand yen2 cm. Material from patients randomized and completing treatment (four cycles of neoadjuvant EC plus 12 weeks of either gefitinib or placebo) in the NICE trial having available ER status both at baseline and after neoadjuvant treatment were eligible for this study. Tumors with indication of changed ER phenotype (based on collected pathology reports) were immunohistochemically reassessed centrally. 115 patients were eligible for this study; 59 patients in the gefitinib group and 56 patients in the placebo group. Five (4.3%) of 115 tumors changed ER phenotype from negative to positive. A change was seen in three patients in the gefitinib (5.1%) and in two patients in the placebo (3.6%) group with a difference of 1.51% (95% CI, -6.1-9.1). Results of the NICE trial have been reported previously. Post-operative reassessment of ER expression changed the assessment of ER status in a small but significant fraction of patients and should, whenever possible, be performed following neoadjuvant chemotherapy for ER negative breast cancer. Gefitinib did not affect the reversion rate of ER negative tumors.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
Breast cancer
Neoadjuvant
Estrogen receptor
Phenotype changes
Post-operative reassessment

Added entries (persons, corporate bodies, meetings, titles ...)

Balslev, Eva (author)
Lykkesfeldt, Anne E. (author)
Kroman, Niels (author)
Harder, Eva (author)
von der Maase, Hans (author)
Jakobsen, Erik H. (author)
Grabau, DortheLund University,Lunds universitet,Kirurgi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Surgery (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)med-dgu (author)
Ejlertsen, Bent (author)
Kirurgi, LundSektion V (creator_code:org_t)

Related titles

In:Breast Cancer Research and Treatment: Springer Science and Business Media LLC128:1, s. 165-1701573-72170167-6806

Internet link

Find in a library

Breast Cancer Research and Treatment (Search for host publication in LIBRIS)

To the university's database

Find more in SwePub

By the author/editor: Bernsdorf, Mogen ...; Balslev, Eva; Lykkesfeldt, Ann ...; Kroman, Niels; Harder, Eva; von der Maase, H ...; show more...; Jakobsen, Erik H ...; Grabau, Dorthe; Ejlertsen, Bent; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: Breast Cancer Re ...

By the university: Lund University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se